Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Observational, Multi-centre Study to Document QoL of Subjects With Acromegaly Under Lanreotide Autogel® Treatment.

NCT02396966 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02396966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02396966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Observational, Multi-centre Study to Document QoL of Subjects With Acromegaly Under Lanreotide Autogel® Treatment.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
May 31, 2018
Enrollment
152 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly